Discontinuation report TOBRAMYCIN INJECTION, USP
Report ID | 152485 |
Drug Identification Number | 02382814 |
Brand name | TOBRAMYCIN INJECTION, USP |
Common or Proper name | Tobramycin injection |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR |
Packaging size | 2mL 10 vial, 30mL 1 vial |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-01-06 |
Remaining supply date | 2022-01-06 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 6982 & 6979. Last lot 7007753 Expiry October 31, 2016. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-01-12 | French | Compare |
v1 | 2022-01-12 | English | Compare |
Showing 1 to 2 of 2